Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
141.76B | 108.25B | 123.38B | 97.53B | 87.33B | Gross Profit |
141.76B | 310.00B | 123.38B | 97.53B | 87.33B | EBIT |
0.00 | 70.63B | 198.83B | 24.15B | 14.15B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
26.36B | 29.86B | 31.11B | 19.71B | 12.70B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
252.07B | 46.79B | 168.68B | 130.12B | 121.39B | Total Assets |
2.40T | 2.15T | 2.03T | 1.93T | 1.73T | Total Debt |
0.00 | 1.00T | 155.20B | 172.43B | 183.96B | Net Debt |
-252.07B | -157.51B | -13.48B | 42.31B | 62.57B | Total Liabilities |
2.21T | 1.98T | 1.87T | 1.79T | 1.60T | Stockholders Equity |
179.62B | 169.24B | 160.28B | 142.00B | 124.57B |
Cash Flow | Free Cash Flow | |||
121.46B | 11.71B | 58.10B | -51.10B | 205.56B | Operating Cash Flow |
127.21B | 13.31B | 64.69B | -46.19B | 209.33B | Investing Cash Flow |
-93.49B | 21.77B | -17.88B | -53.28B | -95.65B | Financing Cash Flow |
-21.36B | -34.34B | -26.98B | -23.78B | -19.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $27.73B | 5.86 | 16.13% | 6.42% | -2.65% | -33.82% | |
81 Outperform | $52.17B | 7.30 | 20.84% | 2.99% | 1.25% | 20.03% | |
70 Outperform | $20.06B | 6.87 | 10.44% | 1.52% | -8.06% | 3.79% | |
66 Neutral | $16.80B | ― | 11.61% | 4.84% | -3.94% | ― | |
64 Neutral | $14.34B | 10.61 | 9.28% | 4.07% | 18.04% | -9.54% |